| Date Filed | Type | Description |
| 05/24/2017 |
8-K
| Quarterly results |
| 05/18/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 05/11/2017 |
8-K
| Form 8-K - Current report |
| 04/21/2017 |
8-K
| Form 8-K - Current report |
| 04/20/2017 |
8-K
| Form 8-K - Current report |
| 03/24/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/15/2017 |
8-K
| Form 8-K - Current report |
| 03/01/2017 |
8-K
| Form 8-K - Current report |
| 02/17/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 02/16/2017 |
8-K
| Form 8-K - Current report |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2017 |
8-K
| Form 8-K - Current report |
| 01/18/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 12/20/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 12/16/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/15/2016 |
8-K
| Form 8-K - Current report |
| 10/14/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 08/23/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 07/20/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 05/19/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 05/13/2016 |
8-K
| Investor presentation |
| 05/04/2016 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 05/02/2016 |
8-K
| Filed for Chapter 11 |
| 04/13/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/13/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/07/2016 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 03/28/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 02/12/2016 |
SC 13G/A
| Visium Asset Management, LP reports a 7.1% stake in NephroGenex, Inc. |
| 01/20/2016 |
SC 13G/A
| BIOSTRATUM Inc reports a 0% stake in NephroGenex, Inc. |
| 12/15/2015 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 12/10/2015 |
4
| Steiner Eugen (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 76,045 shares
@ $0 |
|
| 11/12/2015 |
4
| Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 646,930 shares
@ $0 |
|
| 11/12/2015 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc. |
| 11/12/2015 |
4
| Patel Jaikrishna (Chief Medical Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 97,306 shares
@ $0 |
|
|